Manufacturer record
Mahendra Labs Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Mahendra Labs Pvt. Ltd (Karnataka) were declared Not of Standard Quality between June 2025 and November 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: GP08, Glimepiride Tablets IP.2mg (exp Aug 2027). RDTL, Hubli, Karnataka (state lab) found it not of standard quality: Test for Dissolution. Listed in the November 2025 alert.
Records by type
3 records linked to Mahendra Labs Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Glimepiride Tablets IP.2mg | Batch GP08Mfg Sep 2024 · Exp Aug 2027 | Test for DissolutionDissolution | RDTL, Hubli, KarnatakaState lab | Nov 2025 |
| Ciprox-TZ Suspension - Vet (Ciprofloxacin and Tinidazole Oral Suspension) | Batch CTL184Mfg Oct 2024 · Exp Sep 2026 | Assay for TinidazoleAssay | State Lab KarnatakaState lab | Jun 2025 |
| Albendazole Tablets IP 400 mg | Batch ZL70Mfg Oct 2023 · Exp Sep 2026 | DissolutionDissolution | State Lab KarnatakaState lab | Jun 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.